Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerations

BackgroundWe tested whether a model identifying prostate cancer (PCa) patients at risk of pT3-4/pN1 can be developed for use during COVID19 pandemic, in order to guarantee appropriate treatment to patients harboring advanced disease patients without compromising sustainability of care delivery.Metho...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Luigi Nocera, Lara F. Stolzenbach, Claudia Collà Ruvolo, Mike Wenzel, Christoph Wurnschimmel, Zhe Tian, Giorgio Gandaglia, Nicola Fossati, Vincenzo Mirone, Felix K. H. Chun, Shahrokh F. Shariat, Markus Graefen, Fred Saad, Francesco Montorsi, Alberto Briganti, Pierre I. Karakiewicz
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-12-01
coleção:	Frontiers in Oncology
Assuntos:	radical prostatectomy Pt3+ PT3 pT4 PCA prostate cancer
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2022.990851/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!